Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1227798-75-5 | MDL No. : | MFCD08751406 |
Formula : | C11H16ClNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | SEBSLTSQSAXLOG-RFVHGSKJSA-N |
M.W : | 213.70 | Pubchem ID : | 66518710 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 63.89 |
TPSA : | 21.26 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | Yes |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.71 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 2.66 |
Log Po/w (WLOGP) : | 2.22 |
Log Po/w (MLOGP) : | 2.01 |
Log Po/w (SILICOS-IT) : | 2.48 |
Consensus Log Po/w : | 1.87 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.03 |
Solubility : | 0.201 mg/ml ; 0.000942 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.76 |
Solubility : | 0.373 mg/ml ; 0.00175 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.45 |
Solubility : | 0.0755 mg/ml ; 0.000353 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.75 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 854391-95-0 ]
Bis(4-methoxybenzyl)amine hydrochloride
Similarity: 0.86
[ 244145-40-2 ]
(S)-1-(4-Methoxyphenyl)propan-1-amine hydrochloride
Similarity: 0.86
[ 1158533-04-0 ]
1-(4-Methoxybenzyl)piperidin-4-amine hydrochloride
Similarity: 0.85
[ 730980-51-5 ]
(R)-6-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.84
[ 41566-77-2 ]
5-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride
Similarity: 0.84
[ 57196-62-0 ]
6-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride
Similarity: 0.86
[ 854391-95-0 ]
Bis(4-methoxybenzyl)amine hydrochloride
Similarity: 0.86
[ 244145-40-2 ]
(S)-1-(4-Methoxyphenyl)propan-1-amine hydrochloride
Similarity: 0.86
[ 1158533-04-0 ]
1-(4-Methoxybenzyl)piperidin-4-amine hydrochloride
Similarity: 0.85
[ 42923-77-3 ]
6-Methoxy-1,2,3,4-tetrahydroisoquinoline
Similarity: 0.84
[ 1158533-04-0 ]
1-(4-Methoxybenzyl)piperidin-4-amine hydrochloride
Similarity: 0.85
[ 914348-90-6 ]
2-(6-Methoxynaphthalen-2-yl)piperazine
Similarity: 0.84
[ 1185121-45-2 ]
2-(4-(Trifluoromethoxy)phenyl)pyrrolidine hydrochloride
Similarity: 0.82
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.81
[ 1171560-33-0 ]
3-(4-Methoxyphenyl)morpholine hydrochloride
Similarity: 0.79
[ 1185121-45-2 ]
2-(4-(Trifluoromethoxy)phenyl)pyrrolidine hydrochloride
Similarity: 0.82
[ 1095545-66-6 ]
3-(3-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.81
[ 38175-35-8 ]
3-(3-Methoxyphenyl)pyrrolidine
Similarity: 0.79
[ 207989-87-5 ]
5-(4-Hydroxyphenyl)pyrrolidin-2-one
Similarity: 0.78
[ 1106941-26-7 ]
3-(2-Methoxyphenyl)pyrrolidine hydrochloride
Similarity: 0.77